Cagrilintide
Long-Acting Amylin Analogue
A long-acting amylin analogue studied for appetite regulation and metabolic effects.
Overview
Cagrilintide is a long-acting amylin analogue designed to mimic the effects of the naturally occurring pancreatic hormone amylin. Research has investigated its role in satiety signaling, gastric emptying, and glucagon suppression.
Research Information
Research on cagrilintide has demonstrated its ability to reduce food intake and body weight in animal models. Studies have explored its synergistic potential when combined with GLP-1 receptor agonists. Research has also investigated its effects on glucagon levels, gastric emptying rate, and lipid metabolism.
Research Dosage Reference
Research protocols use subcutaneous administration with weekly dosing schedules. All dosing information is for research reference only.
Related Research
Disclaimer: All information provided is for educational and research purposes only. This is not medical advice. These compounds are not approved for human use. Always consult with qualified professionals before conducting research.